chapter 13 Flashcards
a chronic lung disease characterized by inflammation of the airways and bronchoconstriction, which improves either spontaneously or with treatment
asthma
mediated through b2 receptors, located on bronchioles
bronchospasm
may be rapidly relieved by inhaled brochodilators; occurs within minutes, while inflammation(mucous secretion) is slower in onset, taking hours
bronchospasm
acute exposure, whether allergy or exercise, causes acute bronchospasm
early asthmatic response
airway inflammation comes on more slowly
late asthmatic response
signs or symptoms bronchospasm
wheezing
prolonged or troublesome cough
difficulty breathing
breathlessness(dyspnea)
chest tightness
taken daily on a long-term basis to achieve and maintain control of persistant asthma; anti-inflammatory effects
long term control medications(long term preventive controller, or maintenance medications
quick reversal of acute airflow obstruction and relief of bronchospasm
quick relief meds
suppress cough
antitussives
inhibit histamine release
mast cell stabilizers
suppress inflammation
glucocorticoids
produce thinner mucous
expectorants
loosen mucous
mucolytics
dilate bronchi
beta adrenergic agonists and anticholinergics
provide the quickest onset(5 to 15 mins) and relief of symptoms by bronchodilation
b2 agonists
prototype for short acting b2 receptor selective agonist is
albuterol
quick relief meds for bronchospasms
short acting b2 receptor selective agonists
anticholinergics
systemic corticosteroids
prototype for anticholinergic
atrovent(smooth muscle); ipratropium bromide HFA
regulation of airway smooth muscle tone
anticholinergic
most potent and effective antiinflammatory agents; should be first-line therapy for long-term management of mild, moderate and severe persistent asthma
corticosteroids
what do corticosteroids end in
sone and ide
adverse effects of corticosteroids(inhaled)
cough, oral candidiasis, and with high doses, growth suppression
drug of choice for persistent asthma
inhaled corticosteroids